Paper74282
Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus.
Crooke ST and 5 others. Cancer Treat Rep, 1977. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus. Papers, record 74282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/74282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bleomycin | Major topic |
| Kidney | Major topic |
| Adolescent | |
| Adult | |
| Biological Assay | |
| Creatinine | |
| Humans | |
| Injections, Intravenous | |
| Middle Aged | |
| Neoplasms | |
| Radioimmunoassay | |
| Streptomyces |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41879177 | Pharmacokinetics of bleomycin in dogs treated with electrochemotherapy. | Vet Q | 2026 | https://conductscience.org/library/papers/41879177 | PubMed |
| 25905565 | Structural features facilitating tumor cell targeting and internalization by bleomycin and its disaccharide. | Biochemistry | 2015 | https://conductscience.org/library/papers/25905565 | PubMed |
| 9792151 | Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9792151 | PubMed |
| 9111706 | Cancer chemotherapy in older adults. A tolerability perspective. | Drugs Aging | 1997 | https://conductscience.org/library/papers/9111706 | PubMed |
| 6994913 | The practical benefits of pharmacokinetics in the use of antineoplastic agents. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6994913 | PubMed |
| 6183016 | Bleomycin clinical pharmacology by radioimmunoassay. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6183016 | PubMed |
| 3555940 | Pharmacokinetics of anticancer drugs in children. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3555940 | PubMed |
| 3311530 | Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311530 | PubMed |
| 3060292 | Guide to drug dosage in renal failure. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3060292 | PubMed |
| 2191847 | Antineoplastic drugs in 1990. A review (Part II). | Drugs | 1990 | https://conductscience.org/library/papers/2191847 | PubMed |
| 1696567 | Phase I trial of tallysomycin S10b, a bleomycin analogue. | Invest New Drugs | 1990 | https://conductscience.org/library/papers/1696567 | PubMed |
| 86392 | Bleomycin pharmacokinetics in man. I. Intravenous administration. | Cancer Chemother Pharmacol | 1978 | https://conductscience.org/library/papers/86392 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/74282
GET https://conductscience.org/api/papers/v1/74282/authors